News Opinion Conversations in Cardiology Conversations in Cardiology: The Push for High-Sensitivity Troponin August 02, 2019
News Daily News Adherence to US Physical Activity Guidance Flattens as Sedentary Time Creeps Up Shelley Wood July 26, 2019
News Daily News Thwarted Access to PCSK9 Inhibitors Linked to Greater Risk of Major CV Events Marcus A. Banks July 25, 2019
News Conference News SCCT 2019 Retrospective Study Validates CAC-DRS Score for Predicting Mortality Yael L. Maxwell July 23, 2019
News Conference News SCCT 2019 Chest Pain Rule-Out? For Two ED Scores, It’s a Draw Yael L. Maxwell July 19, 2019
News Conference News SCCT 2019 Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions Yael L. Maxwell July 18, 2019
News Conference News SCCT 2019 CTA or Function Tests in High-risk Chest Pain and No Known CAD: Debate Goes On Yael L. Maxwell July 16, 2019
News Conference News SCCT 2019 Time to Ease Up on Prior Authorization for PCSK9 Inhibitors? Yael L. Maxwell July 15, 2019
News Conference News SCCT 2019 Imaging, Genes, Wearables: Some Predictions for the Future of Preventive Cardiology Yael L. Maxwell July 15, 2019
News Conference News SCCT 2019 Sex-Specific ‘Inventory’ Needed to Spot Key CVD Risk Factors in Women Yael L. Maxwell July 12, 2019
News Conference News SCAI 2019 LDL Apheresis Potentially a ‘Head Start’ to Conventional Lipid-Lowering Methods Post-PCI in ACS: PREMIER Yael L. Maxwell June 03, 2019
News Conference News EAS 2019 FH Patients Derive Biggest Absolute Benefit From Statin Therapy: 4S Analysis Michael O'Riordan June 03, 2019
News Conference News HRS 2019 Cancer Survivors With Heart Failure Respond Well to CRT Todd Neale May 14, 2019
News Daily News In the Wake of Guidelines, Antibiotic Prophylaxis for Infective Endocarditis Declined for Moderate-Risk Patients L.A. McKeown May 07, 2019
News Conference News ACC 2019 Renal Denervation May Lower Treatment Burden, as Well as Blood Pressure: RADIANCE-HTN SOLO Michael O'Riordan April 01, 2019
News Conference News ACC 2019 New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin Shelley Wood March 26, 2019
News Conference News ACC 2019 Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery Michael O'Riordan March 17, 2019
News Conference News ACC 2019 ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend Shelley Wood March 11, 2019